New data suggests delaying 2nd vaccine doses could be risky


This morning, the FDA released new data on Johnson & Johnson’s vaccine that found it’s safe and effective. We’ll hear more about J&J’s coronavirus vaccine on Friday when it goes in front of an FDA expert panel for review ahead of an emergency authorization. 

Also in healthcare news: Data from Scotland’s vaccine rollout suggest delaying second coronavirus vaccine doses could be risky, health systems are building their own health-tech startup, and inside the fallout between Modern Health’s cofounders

vaccine shot
A frontline healthcare worker receives a Moderna COVID-19 vaccination at the Park County Health Departments storefront clinic on January 5, 2021 in Livingston, Montana.

Scotland’s vaccine rollout suggests delaying the 2nd COVID-19 shot is a bad idea

Read the full story from Andrew Dunn here>>

Terry Myerson Microsoft Truveta
Terry Myerson, a former Microsoft exec, will lead Truveta as CEO.

546 hospitals are joining forces to build a new kind of data startup that doesn’t just rely on big tech

Read the full story from Blake Dodge here>>

modern health cofounder breakup 4x3

They launched a $1 billion startup together. Then they broke up. How the relationship between Modern Health’s cofounders died.

Read the full investigation from Melia Russell here>>

More stories we’re reading:

– Lydia

Read the original article on Business Insider